Capitainer AB

🎉Capitainer Initiates Clinical Sampling for HbA1c FDA 510(k) Study - We have officially initiated clinical sampling for our HbA1c study, marking an important step toward our planned FDA 510(k) submission. The study will include at least 120 participants and evaluate both self-sampling and assisted capillary blood collection using Capitainer®B50, with HbA1c results compared against conventional venous blood samples. This study represents another important step in our efforts to explore new opportunities for more accessible and patient-centered blood testing. Read the full press release here: https://lnkd.in/dccj-HPP

What makes a good self-sampling device? 🩸 Hear Mikael Ström, our Business Development Director, briefly explain microsampling and one key difference between conventional dried blood spot sampling (DBS) and volumetric microsampling: knowing exactly how much blood has been collected. Collecting an exact volume is one of several factors that determine whether a self-sampling device can deliver what both the user and the laboratory need. In our latest article, we take a closer look at what makes a self-sampling device reliable, practical, and suitable for use – from both the user and laboratory perspectives. 🔗 Read the full article here: https://lnkd.in/daf4iJvU

What makes Capitainer different from traditional DBS? DBS punches collect area, not volume. Capitainer meters blood with pipette-level precision, ensuring the same sample volume every time 🧪

🚀 NYHET - Life Genomics lanserar egenprovtagning för sköldkörtelfunktion med hjälp av Capitainers innovativa provtagningsteknik! Det nya TSH-testet är utvecklat för att förenkla och effektivisera provtagningen inom mödra- och primärvården. Patienten tar enkelt sitt prov själv hemma och skickar det därefter till Life Genomics ackrediterade laboratorium i Göteborg för analys. Med Capitainers teknik blir provtagningen smidig, precis och flexibel – utan behov av kyltransport. 👉 Läs mer om hur Capitainers teknologi används vid TSH-testning på vår hemsida.

User variability is one of the biggest threats to sample quality. Capitainer’s microsampling devices eliminate manual volume estimation by automatically metering an exact amount of blood – every time. The result? ✅ Consistent sample quality across users and locations ✅ Fewer rejected samples ✅ Higher confidence in downstream data Whether you're running decentralized trials, national screening or clinical diagnostics – precision at the point of collection leads to more reliable outcomes. 👉 Discover how precision sampling improves outcome quality on our website!

🩸Capitainer enables precise and reliable microsampling – without the need for centralized phlebotomy. Our decentralized platform gives you the flexibility to scale sampling operations, reach remote populations, and ensure high-quality results – every time. Proven accuracy. Seamless logistics. 👉 Discover the technology behind scalable blood sampling!